Literature DB >> 2045402

A comparison of quality of life before and after arthroplasty in patients who had arthrosis of the hip joint.

I Wiklund1, B Romanus.   

Abstract

Quality of life before and one year after total hip arthroplasty was evaluated in fifty-six patients who had arthrosis of the hip joint. There were twenty-one men and thirty-five women, and the median age was sixty-five years (range, thirty to seventy-nine years). Before and after total hip arthroplasty, a functional assessment was done with the Charnley-Merle d'Aubigné scoring system. The patients assessed quality of life using the Nottingham Health Profile. In the comparison of quality of life before and after the arthroplasty, significant improvement was observed regarding pain (p less than 0.0001), energy (p less than 0.0001), sleep (p less than 0.0001), and social isolation (p = 0.001). Similarly, there was a significant reduction in the frequency of health-related problems pertaining to housework (p less than 0.0001), holidays (p less than 0.0001), hobbies (p = 0.0001), social life (p less than 0.0001), sexual function (p = 0.001), and family life (p = 0.0005), and among patients who were sixty-five years old or less and who worked at paid employment (p = 0.04). Quality of life after total hip arthroplasty was in close agreement with that of a healthy reference group of similar age and sex distribution. It was concluded that quality of life after total hip arthroplasty is improved considerably. The Nottingham Health Profile is a valuable tool in the evaluation of the result of, as well as the indicators for, total hip arthroplasty.

Entities:  

Mesh:

Year:  1991        PMID: 2045402

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  32 in total

1.  Non-surgical treatment of osteoarthritis: a half century of "advances".

Authors:  K D Brandt
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

2.  Occupational work and quality of life in osteoarthritis patients.

Authors:  Elzbieta Łastowiecka; Joanna Bugajska; Andrzej Najmiec; Maria Rell-Bakalarska; Irena Bownik; Anna Jedryka-Góral
Journal:  Rheumatol Int       Date:  2006-11-09       Impact factor: 2.631

3.  Quality of life and functional ability in hip and knee replacements: a prospective study.

Authors:  P Rissanen; S Aro; H Sintonen; P Slätis; P Paavolainen
Journal:  Qual Life Res       Date:  1996-02       Impact factor: 4.147

4.  Total hip replacement: indications for surgery and risk factors for failure.

Authors:  R W Crawford; D W Murray
Journal:  Ann Rheum Dis       Date:  1997-08       Impact factor: 19.103

5.  Comparison of measures to assess outcomes in total hip replacement surgery.

Authors:  J Dawson; R Fitzpatrick; D Murray; A Carr
Journal:  Qual Health Care       Date:  1996-06

6.  rna interference targeting p110β reduces tumor necrosis factor-alpha production in cellular response to wear particles in vitro and osteolysis in vivo.

Authors:  Jian-bin Huang; Yue Ding; Dong-sheng Huang; Wei-ke Zeng; Zhi-ping Guan; Mao-lin Zhang
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

7.  Individual-patient monitoring in clinical practice: are available health status surveys adequate?

Authors:  C A McHorney; A R Tarlov
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

8.  Employment status and personal characteristics in patients awaiting hip-replacement surgery.

Authors:  Eric R Bohm
Journal:  Can J Surg       Date:  2009-04       Impact factor: 2.089

9.  The Nottingham Health Profile in rheumatoid arthritis: correlation with other health status measurements and clinical variables.

Authors:  F Sivas; O Erçin; O Tanyolaç; N Barça; S Aydoğ; K Ozoran
Journal:  Rheumatol Int       Date:  2003-08-27       Impact factor: 2.631

10.  Satisfaction with care after total hip or knee replacement predicts self-perceived health status after surgery.

Authors:  Cédric Baumann; Anne Christine Rat; Georges Osnowycz; Didier Mainard; Christian Cuny; Francis Guillemin
Journal:  BMC Musculoskelet Disord       Date:  2009-12-03       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.